Skip to main content

Table 2 Frequency distribution of medical comorbidities across the epidemiologic CDI case definition categories in San Francisco County, California, 2016–2020

From: Association between epidemiologic case definition categories and adverse clinical outcome in patients with Clostridiodes difficile infection in San Francisco County, California: a five-year retrospective cohort study

 

Overall

CA

HCFO

CO-HCFA

n

3274

1322

1180

772

Liver disease (%)

174 (5.3)

71 (5.4)

10 (0.8)

93 (12.0)

AIDS (%)

45 (1.4)

24 (1.8)

1 (0.1)

20 (2.6)

HIV (%)

104 (3.2)

52 (3.9)

4 (0.3)

48 (6.2)

Heart failure (%)

228 (7.0)

72 (5.4)

22 (1.9)

134 (17.4)

Hematologic malignancy (%)

62 (1.9)

26 (2.0)

4 (0.3)

32 (4.1)

Non metastatic solid organ tumor (%)

179 (5.5)

94 (7.1)

13 (1.1)

72 (9.3)

Metastatic solid organ tumor (%)

112 (3.4)

45 (3.4)

8 (0.7)

59 (7.6)

Organ transplant recipient (%)

46 (1.4)

21 (1.6)

3 (0.3)

22 (2.8)

Stem cell transplant recipient (%)

12 (0.4)

6 (0.5)

0 (0.0)

6 (0.8)

Diverticulosis (%)

150 (4.6)

89 (6.7)

2 (0.2)

59 (7.6)

Inflammatory bowel disease (%)

134 (4.1)

103 (7.8)

2 (0.2)

29 (3.8)

CKD (%)

473 (14.4)

221 (16.7)

28 (2.4)

224 (29.0)

COPD (%)

303 (9.3)

162 (12.3)

13 (1.1)

128 (16.6)

Diabetes (%)

505 (15.4)

233 (17.6)

39 (3.3)

233 (30.2)

Total

3274

1322 (40.4)

1180 (36)

772 (23.5)

  1. HCFO Healthcare Facility Onset, CO-HCFA Community-Onset Healthcare Facility Associated, CA Community Associated, HIV Human Immunodeficiency Virus, AIDS Acquired Immunodeficiency Syndrome, COPD Chronic Obstructive Pulmonary Disease, CKD chronic kidney disease